In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtechs Must Act Fast On New EU Regulations Or Face Gridlock

Executive Summary

Following the recent vote in the European Parliament, the EU has finally adopted the Medical Device and IVD Regulations that were proposed back in September 2012. The texts, vastly longer and more complex than the three directives they are replacing, will establish a tougher regulatory code for the next decade or more, but where are the likely pressure points for industry and how can manufacturers prepare?

Advertisement

Related Content

Medtech 2018: The Place For Innovation As Value-based Health Care Gains Momentum
The Rozy View: US Medtechs Face New Reg Burdens On Entering EU Market
Where To Turn For Help On The Imminent EU Regulations
Progress report on the Dalli urgent action plan for EU medtech: why the delay, why the silence?
Spectre of widespread breast explantations returns with PIP recall

Topics

Advertisement
UsernamePublicRestriction

Register

IV005037

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel